We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAON icon
12651
PUT
Aaon
AAON
$7.24B
-12,450
Closed -$463K
ABCB icon
12652
CALL
Ameris Bancorp
ABCB
$6.02B
-15,800
Closed -$693K
ABEO icon
12653
Abeona Therapeutics
ABEO
$341M
-3,759
Closed -$29K
ABG icon
12654
Asbury Automotive
ABG
$3.78B
-44,942
Closed -$7.78M
ABOS icon
12655
PUT
Acumen Pharmaceuticals
ABOS
$193M
-20,000
Closed -$78K
ABTS icon
12656
PUT
Abits Group
ABTS
$3.91M
-773
Closed -$19K
ACA icon
12657
Arcosa
ACA
$7.14B
-25,786
Closed -$1.35M
ACCO icon
12658
PUT
Acco Brands
ACCO
$401M
-25,400
Closed -$203K
ACGL icon
12659
PUT
Arch Capital
ACGL
$33.7B
-34,200
Closed -$1.66M
ACEL icon
12660
PUT
Accel Entertainment
ACEL
$1.01B
-15,400
Closed -$188K
ACET icon
12661
PUT
Adicet Bio
ACET
$78.4M
-1,494
Closed -$477K
ACHC icon
12662
Acadia Healthcare
ACHC
$2.87B
-159,760
Closed -$11.1M
ACHC icon
12663
PUT
Acadia Healthcare
ACHC
$2.87B
-12,600
Closed -$826K
ACIU icon
12664
CALL
AC Immune
ACIU
$253M
-27,100
Closed -$108K
ACMR icon
12665
ACM Research
ACMR
$5.6B
-242,973
Closed -$3.74M
ACNB icon
12666
ACNB Corp
ACNB
$660M
-13,092
Closed -$458K
ACT icon
12667
Enact Holdings
ACT
$6.87B
-22,196
Closed -$508K
ACTG icon
12668
PUT
Acacia Research
ACTG
$448M
-35,800
Closed -$161K
ACTV
12669
DELISTED
LeaderShares Activist Leaders ETF
ACTV
-9,333
Closed -$336K
ACWV icon
12670
CALL
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
-2,000
Closed -$210K
ACWV icon
12671
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
-2,447
Closed -$256K
ADAP
12672
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
-14,800
Closed -$30K
ADV icon
12673
PUT
Advantage Solutions
ADV
$420M
-552
Closed -$88K
AEG icon
12674
CALL
Aegon
AEG
$14B
-13,697
Closed -$69K
AEIS icon
12675
Advanced Energy
AEIS
$13.2B
-33,029
Closed -$2.55M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.